This inventor holds 8 USPTO granted patents. Top assignees: Dainippon Pharmaceutical Company, Limited, Ono Pharmaceutical Co., Ltd.. Active years: 1976-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JA (1976)
- Hirakata, JP (1979)
- Osaka, JP (1989)
- Katano, JP (1985 - 2002)
Company Filing History:

Years Active: 1976-2002
Title: The Innovations of Yoshinobu Masuda
Introduction
Yoshinobu Masuda is a prominent inventor based in Katano, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. With a total of 8 patents to his name, Masuda's work has the potential to impact the lives of many individuals suffering from these conditions.
Latest Patents
Masuda's latest patents include a remedy for neurodegenerative diseases. This invention provides a medicament comprising zonisamide or an alkali metal salt thereof as an active ingredient. The medicament can be utilized in the prevention and treatment of various neurodegenerative diseases, including Parkinson's disease, Huntington's disease, choreic syndrome, and dystonic syndrome in mammals, including humans. Another notable patent is an ameliorant for blood lipid metabolism, which showcases his innovative approach to addressing health issues.
Career Highlights
Throughout his career, Yoshinobu Masuda has worked with several reputable companies, including Dainippon Pharmaceutical Company, Limited and Ono Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical science.
Collaborations
Masuda has collaborated with notable colleagues, including Mikio Kurokawa and Hitoshi Uno. These partnerships have fostered a creative environment that has led to the development of groundbreaking solutions in the medical field.
Conclusion
Yoshinobu Masuda's contributions to the field of medicine through his innovative patents demonstrate his commitment to improving health outcomes. His work continues to inspire future advancements in the treatment of neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile